FDA plans to put out separate guidances specifying the electronic format for certain types of submissions under NDAs, ANDAs, BLAs, and the final versions of these individual guidances will start the clock on when sponsors will be required to submit those specific submissions in electronic format.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?